Komplizierte Haut- und Weichgewebeinfektionen - Moxifloxacin erobert neue Indikationsbereiche

Literatur

• 1 Giordano P, Song J, Mendelson M, Choudhri S. Sequential iv/po moxifloxacin vs. iv piperacillin-tazobactam ± po amoxicillin-clavulanate for treatment of complicated skin and skin structure infection.  44th Interscience Conference on Antimicrobial Agents and Chmotherapy (ICAAC 2004), Poster L. 987
• 2 Malangoni M. et al. . Sequential iv/po Moxifloxacin vs. iv piperacillin-tazobactam ± po amoxicillin-clavulanate for treatment of complicated intra-abdominal infections.  Poster, 44. Annu Intersci Conf Antimicrob Agents Chemother (ICAAC), Washington, USA. 2004;